Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
高成長
同社の収益は過去3年間にわたり着実に増加しており、年平均で33.15%の成長率を示しています。
成長中
同社は成長フェーズにあり、最新の年間収益はUSD 64.00Mに達しています。
高い利益成長
同社の純利益は業界をリードしており、最新の年間純利益はUSD 64.00Mです。
適正水準
同社の最新のPEは27.30で、過去3年間の水準と比較して適正圏にあります。
機関投資家の売り越し
最新の機関投資家の保有株数は4.37M株で、前四半期比で3.35%減少しています。